<DOC>
	<DOCNO>NCT01843231</DOCNO>
	<brief_summary>This study multi-center , open/unblended study ( 3:1Treatment : Control ) evaluate safety effectiveness g-Cath EZ Suture Anchor Delivery Catheter early weight loss intervention compare diet exercise control . Mean % Total Body Weight Loss [ TBWL ] Treatment subject versus Control subject 12 month primary endpoint . The proportion subject achieve ≥ 5 % TBWL 12 month treatment group co-primary endpoint .</brief_summary>
	<brief_title>Use Incisionless Operating Platform Primary Treatment Obesity vs. Diet-Exercise Alone</brief_title>
	<detailed_description>This study evaluate safety effectiveness g-Cath EZ Suture Anchor Delivery Catheter early weight loss intervention compare diet exercise control . The weight loss outcome use assess treatment effect . This study multi-center , open/unblinded , prospective randomize feasibility study ( 3:1Treatment : Control ) study . Patients control group offer opportunity crossover treatment group 12 month .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>Age 2060 year Body Mass Index [ BMI ] &gt; 30 &lt; 40 without comorbid condition Subject fail conservative weight reduction alternative supervise diet , exercise behavior modification program last year No significant weight change ( +/ 5 % total body weight ) last 6 month American Society AnesthesiologistsPhysical Status score ≤ 2 ( Appendix III ) , Subject agree additional weight loss interventional procedure liposuction least 30 month follow study enrollment , Has take prescription counter weight loss medication least 6 month , Signed informed consent . Subject willing cooperate postoperative dietary recommendation assessment test , History ( intraoperative evidence ) bariatric , gastric esophageal surgery Esophageal stricture anatomy and/or condition could preclude passage endolumenal instrument Severe gastroesophageal reflux disease ( GERD ) , define symptom cause subject severe discomfort , compromise performance daily activity , and/or condition entirely control prescription drug therapy Known hiatal hernia &gt; 3 centimeter history determine Upper Gastrointestinal exam endoscopy Pancreatic insufficiency/disease Active peptic ulcer Pregnancy plan pregnancy next 12 month Present Corticosteroid Use History inflammatory disease Gastrointestinal [ GI ] tract ; Coagulation disorder ; hepatic insufficiency cirrhosis History present use insulin insulin derivative treatment diabetes Type II Diabetes Mellitus [ DM ] ( define Glycosylated Hemoglobin [ HgbA1c ] &gt; 6.5 ) great 2 year time enrollment Uncontrolled Type II DM ( HgbA1c &gt; 7.0 screening ) Quit smoking within last 6 month time enrollment plan quit smoke next year Immunosuppression Portal hypertension and/or varix Active gastric ulcer disease Gastric outlet obstruction stenosis Beck Depression Inventory ( Short ) Score ≥12 ( see Appendix IV ) ; Subject history drug alcohol abuse actively abuse either defined Cage DAST [ drug use ] questionnaire positive Urinalysis [ UA ] drug screen Severe disturbances eat behavior ( i.e . binge eat ) Known presence significant depression , psychosis , mood eat disorder Actively treat depression ( except stable treated depression &gt; 1year normal [ Beck Depression Inventory [ BDI ] psych exam ) Present past history psychosis mood eat disorder Nonambulatory significant impairment mobility Known hormonal genetic cause obesity exception treat hypothyroidism . Participating another clinical study Is first degree relative investigator , support staff involve study . Employed investigator institution involve study Subject able provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>g-Cath EZ Suture Anchor Delivery Catheter</keyword>
	<keyword>Weight Loss Intervention</keyword>
</DOC>